Source: Eur Respir Rev, 29 (156) 190168; 10.1183/16000617.0168-2019
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jason Weatherald, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert, David Montani. Pulmonary capillary haemangiomatosis: a distinct entity?. Eur Respir Rev, 29 (156) 190168; 10.1183/16000617.0168-2019

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary embolism and COVID-19: a “special phenotype”? Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 Combined pulmonary fibrosis and emphysema: A distinct entity? Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis Source: Eur Respir Mon 2012; 57: 182-193 Year: 2012 Pulmonary hypertension: a paradigm for rare pulmonary diseases Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017 Year: 2017 Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Source: Eur Respir J 2010; 35: 223-224 Year: 2010 Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002 Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis? Source: International Congress 2014 – ILDs 1 Year: 2014 A case of pulmonary capillary haemangiomatosis (PCH) diagnosed by lung biopsy Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Pulmonary embolism with a rare etiology: a case report Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Systemic vascularization in intralobar pulmonary sequestration - congenital or acquired? Source: Eur Respir J 2001; 18: Suppl. 33, 492s Year: 2001 Propanolol treatment in pulmonary capillary hemangiomatosis Source: Annual Congress 2011 - Rare lung diseases in children Year: 2011 Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn Source: International Congress 2015 – Neonatal and paediatric intensive care Year: 2015 Secondary bronchogenic pulmonary hydatidosis: a rare entity Source: Virtual Congress 2021 – Oncology, the mediastinum and infectious lung disease Year: 2021 Lung fibrosis in Pulmonary Alveolar Proteinosis (PAP): different stages of a syndrome or distinct diseases? Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Multi nodular parenchymal pulmonary amyloidosis in primary Sjogren‘s syndrome: A case report Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Smoking-related intersticial fibrosis (srif): A new entity? Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary hypertension in orphan lung diseases Source: Eur Respir Mon 2011; 54: 317-331 Year: 2011 Pulmonary hypertension and pulmonary vascular disease: course report Source: Breathe, 14 (1) e4; 10.1183/20734735.019917 Year: 2018 Pulmonary embolism: still often underdiagnosed Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases" Year: 2017